Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

5(83.3%)

Phase 3

1(16.7%)

6Total

N/A(5)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT03438747Not ApplicableActive Not Recruiting

P-15L Bone Graft in Transforaminal Lumbar Interbody Fusion With Instrumentation

Role: lead

NCT05038527Not ApplicableRecruiting

ABM/P-15 Bone Graft vs Traditional Bone Graft in Adult Spinal Deformity Surgery

Role: collaborator

NCT02895555Not ApplicableCompleted

The Clinical Effect of i-FACTOR® Versus Allograft in Non-instrumented Posterolateral Fusion The IVANOS-study

Role: collaborator

NCT05144126Not ApplicableUnknown

Safety, Radiological and Patient Reported Outcomes of i-FACTOR+ Matrix Bone Graft Device - A Canadian, Multicenter, Post-Market Clinical Investigation

Role: lead

NCT00310440Not ApplicableCompleted

An Assessment of P-15 Bone Putty in Anterior Cervical Fusion With Instrumentation

Role: lead

NCT01618435Phase 3Unknown

The Clinical Effect of i-FACTOR® Versus Allograft in Non-instrumented Posterolateral Spondylodesis Operation in the Elderly With Spinal Stenosis Due to Degenerative Spondylolisthesis

Role: collaborator

All 6 trials loaded